stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Regeneron Pharmaceuticals IncREGN
$945.531.28%-12.23

Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals Inc stock is traded at $945.53, with a volume of 704,314. It is down -1.28% in the last 24 hours and up +19.58% over the past month. Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Previous Close:
$957.76
Open:
$957.25
24h Volume:
704,314
Relative Volume:
0.71
Market Cap:
$97.81B
Revenue:
$14.92B
Net Income/Loss:
$4.42B
P/E Ratio:
23.04
EPS:
$41.04
Net Cash Flow:
$3.79B
1W Performance:
-1.45%
1M Performance:
+19.58%
6M Performance:
+50.16%
1Y Performance:
+30.36%
1-Day Range:
$943.26$972.00
1-Week Range:
$942.00$972.24
52-Week Range:
$591.52$991.73

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
Regeneron Pharmaceuticals Inc
Phone
(914) 847-7000
Address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, USA
Employee
15,410
Next Earnings Date
-
Latest SEC Filings
SEC
REGN's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Regeneron Pharmaceuticals Inc Stock (REGN) Financials Data

Similar to REGN